Free Trial
LON:AVO

Advanced Oncotherapy (AVO) Share Price, News & Analysis

Advanced Oncotherapy logo

About Advanced Oncotherapy Stock (LON:AVO)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
200,000 shs
Average Volume
1.27 million shs
Market Capitalization
£9.50 million
P/E Ratio
N/A
Dividend Yield
5.49%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AVO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Advanced Oncotherapy and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AVO Stock News Headlines

AVO.L Regulatory News
Missed the Last 10,000% Surge? Here’s Your Next Chance
Axcelis Technologies went from $2.50 to $180—a staggering 7,100% return. These are the kinds of small-cap breakouts Fierce Analyst aims to catch before they go mainstream. Our research team uses data and trend analysis to uncover high-potential stocks early. And now, you can get free alerts on the next set of breakout candidates—before the crowd rushes in.tc pixel
Advanced Oncotherapy Share Chat
Advanced Oncotherapy PLC AVO
See More Headlines

AVO Stock Analysis - Frequently Asked Questions

Advanced Oncotherapy plc (LON:AVO) issued its quarterly earnings data on Monday, June, 29th. The company reported ($9.83) earnings per share for the quarter, missing the consensus estimate of ($8.90) by $0.93.

Shares of AVO stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Advanced Oncotherapy investors own include UK Oil & Gas (UKOG), Academy Sports and Outdoors (ASO), Renishaw (RSW), Tullow Oil (TLW), BMR Group (BMR), Lancashire (LRE) and Sirius Minerals (SXX).

Company Calendar

Last Earnings
6/29/2020
Today
8/28/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Medical Devices
Sub-Industry
Agriculture
Current Symbol
LON:AVO
CIK
N/A
Fax
N/A
Employees
3,900
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX (0.07)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£32.60 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-67.34%
Return on Assets
-11.73%

Debt

Debt-to-Equity Ratio
98.71
Current Ratio
1.26
Quick Ratio
0.13

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
33.50
Book Value
GBX 14 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
542,570,000
Free Float
N/A
Market Cap
£9.50 million
Optionable
Not Optionable
Beta
0.06
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (LON:AVO) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners